Global Blood Therapeutics Inc. (GBT) Fundamentals

Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.
SHARE INFORMATION
Market Cap$ 4,520,068,168
Shares Outstanding67,463,704
Float65,681,880
Percent Float97.36%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 194,749,000
Latest Fiscal EPS$ -4.82
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions498
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months9,728,936
Institutional Holdings Percent166.9%
Institutional Sold Previous 3 Months18,758,397
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months105,748
Insider Holdings Percent2.7
Insider Sold Previous 3 Months36,976
Insider Shares Owned1,756,278
TRADING INFO
52 Week High$ 73.02
52 Week Low$ 21.65
52 Week High Change$ 149.35
21 Day Moving Average$ 46.8367
21 Day Extended Moving Average$ 51.5764
50 Day Moving Average$ 36.8594
50 Day Extended Moving Average$ 41.615
200 Day Moving Average$ 32.0592
200 Day Extended Moving Average$ 34.2904
10 Day Average Volume9,857,071
20 Day Average Volume5,364,065
30 Day Average Volume3,935,393
50 Day Average Volume3,156,132
Alpha0.008729
Beta0.8328
Standard Deviation0.171730
R20.058832
7 Day Price Change$ 0.41
7 Day Percent Change0.62%
21 Day Price Change$ 33.65
21 Day Percent Change100.9%
30 Day Price Change$ 31.01
30 Day Percent Change86.16%
Month to Date Price Change$ 34.28
Month to Date Percent Change104.77%
Quarter to Date Price Change$ 35.05
Quarter to Date Percent Change109.7%
180 Day Price Change$ 32.56
180 Day Percent Change94.54%
200 Day Price Change$ 39.58
200 Day Percent Change144.35%
Year to Date Price Change$ 37.73
Year to Date Percent Change128.9%

Global Blood Therapeutics Inc. (GBT) Key Ratios

PROFITABILITY
EBIT Margin-126.5%
EBITDA Margin-122.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin98.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 234,861,000
Revenue Per Share$ 3.4813
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book38.20
Total Debt To Equity5.60
Int Coverage-12.00
Current Ratio6.90
Leverage Ratio4.40
Quick Ratio5.90
Long Term Debt To Capital0.85
VALUATION MEASURES
PE Ratio-13.40
Enterprise Value$ 4,663,994,716
Price to Sales19.2457
Price to Free Cash-18.00
PE High Last 5 Years-13.00
Price To Book38.20
Price To Cash Flow0.00
PE Low Last 5 Years-11.60
Price to Tangible Book38.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover10.00
Invoice Turnover0.10
Assets Turnover0.30
Return Assets-45.61
Return on Equity-162.29
Return on Capital-46.71

Global Blood Therapeutics Inc. (GBT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOTed W. Love
Emplyoees457
Last AuditUE
CIK0001629137
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address181 Oyster Point Boulevard
Suite 300
South San Francisco, CA 94080
Websitehttps://www.gbt.com
Facsimile+1 650 741-7701
Telephone+1 650 741-7700
Emailsyao@gbt.com


Your Recent History
NASDAQ
GBT
Global Blo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.